Centessa (CNTA) Pharmaceuticals announced that it has commenced an underwritten public offering of American Depositary Shares, ADSs, each representing one ordinary share. All of the ADSs are being offered by Centessa. Jefferies, Leerink Partners, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering. Oppenheimer & Co., Truist Securities and LifeSci Capital are acting as co-lead managers.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA:
- Centessa Pharmaceuticals: Promising Developments in Sleep Disorder Treatments Drive Buy Rating
- Centessa Pharmaceuticals Advances OX2R Agonist Program
- RBC says Centessa data highlights ‘impressive profile’ of Alkermes’ alixorexton
- Centessa narcolepsy data not superior to Alkermes, says Stifel
- Alkermes jumps 10% after Centessa narcolepsy data